id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-1519-0003,FDA,FDA-2020-N-1519,Revocation of the Human Tissue Intended for Transplantation Regulation and Human Dura Mater PRIA,Other,Background Material,2022-01-14T05:00:00Z,2022,1,2022-01-14T05:00:00Z,,2022-01-14T16:08:32Z,,0,0,0900006484f2123e
FDA-2020-N-1519-0002,FDA,FDA-2020-N-1519,Revocation of the Regulations for Human Tissue Intended for Transplantation and Human Dura Mater,Rule,Final Rule,2022-01-13T05:00:00Z,2022,1,2022-01-13T05:00:00Z,,2022-01-13T14:31:38Z,2022-00492,0,0,0900006484f1e9de
FDA-2020-N-1519-0001,FDA,FDA-2020-N-1519,Revocation of the Regulations for Human Tissue Intended for Transplantation and Human Dura Mater,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2020-12-21T05:00:00Z,2020,12,2020-12-21T05:00:00Z,2021-03-09T04:59:59Z,2022-01-13T14:31:27Z,2020-27828,0,0,09000064849af00a